speb/financial-data huggingface dataset:
Financial scorecard for MEDPLUS.NS (Healthcare — Pharmaceutical Retailers, India)
Report date: 2026-06-30 (quarterly)
Stock price: 7.437551610239471
Market cap: 86527819776 (USD: 912837005.7601012)
P/E ratio: 0.4884704407452368
Debt to equity: 0.7212999999999999
Interest coverage ratio: 1.6627892996693716
Buffett classification: The Great
Analyst consensus upside (%): 11745.27173604687
Rule of 40 score: 0.35875040641484707
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 11.0105282375852, earnings yield % 0.036455925416333766, rank 5546
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -15.92064109951982, 3m -22.542136663571444, 6m -12.176653929129994, 12m -27.569380170796855, composite -16.191082707929397 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue growth 1y (%): 12.358952746057273
Net income growth 1y (%): -41.68004520879192
Revenue deceleration: no
Revenue growth consistency score: 2.688469058814614
Beneish M-score: -2.543899730895793 (Likely Safe)
Net margin (%): 1.7650563949776548
ROE archetype: Standard Business
P/E z-score: 3.738104672754726
FCF z-score: 3.083763191132087
Treasury beta 1y: 0.04666701167468685 (R-squared: 0.0025024580320960094)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 9.25518163146187 (pretax: 11.603640877710063)
Incremental ROIC 3y (%): 46.15664746779331 (pretax: 57.62373245648389)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 36, P/B , ROIC 28.000000000000004, revenue growth 1y 22, 6m momentum 34
Sector percentiles: P/E 10.243553008595988, 6m momentum 42.299426934097426
Industry median P/E: 0.15154711900058024; industry median ROIC: 5.985153957145241
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07109479384567631
Base cash flow: 40261551.504874945
DCF price per share: base 0.12527255346019983, conservative 0.07697331043165083, aggressive 0.2043885768718751
Financial scorecard for MEG.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2024-12-31 (annual)
Stock price: 0.01388888888888889
Market cap: 13692982 (USD: 8504957.763975155)
P/B ratio: 2.1491211032669666
Debt to equity: 0
Current ratio: 17.81
Return on net tangible assets (%): -66.47330489242812
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m -49.30555555555556, 12m -58.05555555555556, composite -36.809386973180075 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 1.0158654565862684
ROE archetype: Standard Business
Treasury beta 1y: 0.0019223386467782087 (R-squared: 1.2806318519171668e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -71.47218143612594 (pretax: -90.47111574193156)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 29.059117402164862, ROIC 47.71024146544546, revenue growth 1y , 6m momentum 61.78184845961698
Sector percentiles: P/E , 6m momentum 70.21099389228208
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06340000000000001
Base cash flow: -2769076.3975155274
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MEI.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.125
Market cap: 523191424 (USD: 341955179.0849673)
P/B ratio: 41.35679261882923
Debt to equity: 0.0042
Current ratio: 5.45
Return on net tangible assets (%): -437.04831293751215
Buffett classification: The Gruesome
Analyst consensus upside (%): 448.25
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.30385379558515085
Debt paydown yield (%): 0.04533595718877839
Total shareholder yield (%): 0.3491897527739293 (Low Return)
Momentum (%): 1m 20.833333333333336, 3m -7.894736842105275, 6m -26.999999999999996, 12m 11.029411764705877, composite -14.336109035265656 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 2.0171763943681746
ROE archetype: Standard Business
Treasury beta 1y: 0.01229848365128615 (R-squared: 0.0024020060231715198)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 59.11740216486261, ROIC , revenue growth 1y , 6m momentum 40.38301415487094
Sector percentiles: P/E , 6m momentum 51.97112715158245
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1497109247453138
Base cash flow: -23900286.928104572
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MHK.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.04861111111111112
Market cap: 8637479 (USD: 5645411.111111111)
P/E ratio: 26.79738562091503
Debt to equity: 0.0286
Current ratio: 18.36
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 40.97222222222225, 3m -24.382716049382715, 6m -49.30555555555555, 12m -80.68347953216374, composite -53.328637419431935 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.0013971152971177488 (R-squared: 2.760707708050185e-05)
Insider 90-day net shares: 250000 (net value USD: 15850.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 13.655287260616152, P/B , ROIC , revenue growth 1y , 6m momentum 61.69858451290591
Sector percentiles: P/E 32.09328151027207, 6m momentum 70.12770682953915
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10465
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MIAX (Financial Services — Capital Markets, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 42.78
Market cap: 4140617984 (USD: 4140617984)
P/E ratio: 30.170542635658915
P/B ratio: 3.535256587922174
Debt to equity: 0.0213
Current ratio: 2.77
Interest coverage ratio: 1021.5111111111111
Return on net tangible assets (%): 20.753165389714887
Buffett classification: The Good
Analyst consensus upside (%): 32.065775950668026
Rule of 40 score: 10.328431224997102
Altman Z-score: 6.990188387124068 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0015215120120581499
Total shareholder yield (%): 0.0015215120120581499 (Low Return)
Momentum (%): 1m 17.237599342285552, 3m -6.736429038587305, 6m 0.8011310084825717, 12m , composite -2.9676490150523667 (Flat)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 10, short score 0, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): 13.028430614197873
Revenue deceleration: no
Accrual ratio: 0.09145122900719595
FCF conversion rate: 0.2737569320424852
Beneish M-score: -2.386393873298061 (Likely Safe)
ROE (%): 17.48960866096468
Net margin (%): 46.04506478400822
Asset turnover: 0.2734792989360502
Equity multiplier (leverage): 1.388905014094
ROE archetype: High-Margin Compounder
FCF z-score: 2.2694737896463155
Treasury beta 1y: 0.003048130851881038 (R-squared: 0.0010825406159301735)
Insider 90-day net shares: -746339 (net value USD: -32854086.00)
ROIC (%): 16.45122352755242 (pretax: 20.824333579180276)
Incremental ROIC 3y (%): 15.997366408576259 (pretax: 20.249830896931968)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 53.2967032967033, P/B 59.61538461538461, ROIC 15.934065934065933, revenue growth 1y 27.747252747252748, 6m momentum 30.494505494505496
Sector percentiles: P/E 51.03466114847387, 6m momentum 38.7997930677703
Industry median P/E: 0.9254498714652956; industry median ROIC: 1.51204420306575
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10407127305276616
Base cash flow: -75518000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MNC.AX (Consumer Cyclical — Apparel Manufacturing, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.05555555555555556
Market cap: 5914125 (USD: 3865441.176470588)
Debt to equity: 0.9009999999999999
Current ratio: 3.93
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -10.49382716049382, 3m -13.580246913580252, 6m -42.06349206349206, 12m -40.079365079365076, composite -29.56597538973018 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 48.48017249292411
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.004623831752533736 (R-squared: 0.0004626306625254012)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 88.53503184713377
Sector percentiles: P/E , 6m momentum 81.05006954102922
Industry median P/E: 0.8420334714862808; industry median ROIC: 4.712308174264459
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.1019
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MPLT (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 36.56
Market cap: 1657837952 (USD: 1657837952)
P/B ratio: 2.1669675276489744
Debt to equity: 0.013999999999999999
Current ratio: 22.91
Return on net tangible assets (%): -15.138782594776831
Buffett classification: The Gruesome
Analyst consensus upside (%): 115.69109690113135
Rule of 40 score: 0
Altman Z-score: 51.460250932139076 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.012727420056070715
Total shareholder yield (%): 0.012727420056070715 (Low Return)
Momentum (%): 1m 19.282218597063636, 3m 22.8494623655914, 6m 103.33704115684095, 12m , composite 63.09325176121618 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.021075364577535345
FCF conversion rate: 0.8439704621876443
Beneish M-score: -2.795883531946015 (Likely Safe)
ROE (%): -14.138330424163895
Asset turnover: 0
Equity multiplier (leverage): 1.0467183869607064
ROE archetype: Low Return
Treasury beta 1y: -0.011107709798547558 (R-squared: 0.004491609411750674)
Insider 90-day net shares: -809405 (net value USD: -25457067.00)
ROIC (%): -83.97229539010883 (pretax: -106.29404479760609)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 25.812274368231048, ROIC 23.375451263537904, revenue growth 1y , 6m momentum 2.527075812274368
Sector percentiles: P/E , 6m momentum 1.9699140401146131
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1015228715788067
Base cash flow: -161047000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NAMS (Healthcare — Biotechnology, Netherlands)
Report date: 2026-03-31 (quarterly)
Stock price: 30.09
Market cap: 3465033728 (USD: 3465033728)
P/B ratio: 4.894041147131784
Debt to equity: 0
Current ratio: 9.76
Return on net tangible assets (%): -7.282427385548855
Buffett classification: The Gruesome
Analyst consensus upside (%): 56.57606997813184
Rule of 40 score: 7581.477616454929
Altman Z-score: 25.986646792422206 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.006095475363128529
Total shareholder yield (%): 0.006095475363128529 (Low Return)
Momentum (%): 1m -7.784247624885082, 3m 1.2449528936742968, 6m -9.693877551020408, 12m 28.644719965797343, composite 10.351712302475056 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue growth 1y (%): 7.948712010683723
Revenue deceleration: no
Accrual ratio: -0.023419308515278466
FCF conversion rate: 0.6325633244565554
Beneish M-score: 78.4535853655859 (Strong Manipulation Signal)
ROE (%): -7.09896721331557
Net margin (%): -1593.453947368421
Asset turnover: 0.003999926843443258
Equity multiplier (leverage): 1.1137907470457047
ROE archetype: Low Return
Treasury beta 1y: -0.0024928679823547724 (R-squared: 0.0003563107271588751)
Insider 90-day net shares: -210000 (net value USD: -6713665.00)
ROIC (%): -376.2018273126267 (pretax: -476.2048446995275)
Incremental ROIC 3y (%): -216.08221601777174 (pretax: -273.5217924275591)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 45.667870036101085, ROIC 35.92057761732852, revenue growth 1y 15.433212996389893, 6m momentum 34.92779783393502
Sector percentiles: P/E , 6m momentum 39.79226361031519
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05130010573209339
Base cash flow: -239817647.05882356
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NHE.AX (Basic Materials — Specialty Chemicals, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.020833333333333332
Market cap: 21386226 (USD: 13977925.490196079)
Debt to equity: 0.1864
Current ratio: 0.02
Buffett classification: The Gruesome
Analyst consensus upside (%): 818
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 51.04166666666664, 3m -2.7777777777777843, 6m 1.3888888888888888, 12m 4.861111111111101, composite -10.654533844189016 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.0026640077333038564 (R-squared: 4.269523909833204e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 46.51162790697674
Sector percentiles: P/E , 6m momentum 20.655191560244308
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NIBL.NS (Industrials — Tools & Accessories, India)
Report date: 2026-03-31 (annual)
Stock price: 0.38170933113129646
Market cap: 896049408 (USD: 9496072.573124206)
Debt to equity: -1.0127791585783998
Current ratio: 0.77
Interest coverage ratio: -1.5626596046533623
Buffett classification: The Gruesome
Rule of 40 score: -3.686859864961048
Altman Z-score: -1.9066481216157953 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.9030039885717422
Total shareholder yield (%): -1.9030039885717422 (Minimal or Negative)
Momentum (%): 1m 22.864707937358123, 3m 18.713367986669887, 6m 12.341068332952448, 12m 25.73269618659557, composite 11.12956720814399 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): 15.822213535779127
Net income growth 1y (%): -115.46829436349597
Revenue deceleration: no
Revenue growth consistency score: 7.201655719037848
Beneish M-score: -0.28912739151652056 (Strong Manipulation Signal)
Net margin (%): -32.7567021230071
Asset turnover: 0.1705453659474457
ROE archetype: Standard Business
Treasury beta 1y: 0.0003112954607765098 (R-squared: 4.709596018720961e-06)
Insider 90-day net shares: 201741 (net value USD: 69627.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 8.450704225352112, 6m momentum 30.985915492957744
Sector percentiles: P/E , 6m momentum 23.067076292882742
Industry median P/E: 0.20276750382501746; industry median ROIC: 6.456997816419219
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.07727524541575397
Base cash flow: -2541278.0839338703
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NKTX (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.27
Market cap: 162407968 (USD: 162407968)
P/B ratio: 0.5280931413279227
Debt to equity: 0.26239999999999997
Current ratio: 12.96
Return on net tangible assets (%): -9.062128314559574
Buffett classification: The Gruesome
Analyst consensus upside (%): 436.96682464454983
Rule of 40 score: 0
Altman Z-score: -0.9856311539423779 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.8743413377353505
Total shareholder yield (%): 0.8743413377353505 (Low Return)
Momentum (%): 1m -21.453287197231838, 3m -22.260273972602736, 6m -8.835341365461854, 12m 6.074766355140182, composite 1.3170378779660084 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.0020095789932009244
FCF conversion rate: 1.0280252946248922
Beneish M-score: -2.121764611391804 (Likely Safe)
ROE (%): -9.305482417646713
Asset turnover: 0
Equity multiplier (leverage): 1.297728963447763
ROE archetype: Low Return
Treasury beta 1y: 0.01064779594646752 (R-squared: 0.0038304150548126004)
Insider 90-day net shares: -1776 (net value USD: -4813.00)
ROIC (%): -85.69490334856756 (pretax: -108.47456120071843)
Incremental ROIC 3y (%): -25.38212927756654 (pretax: -32.129277566539926)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 6.046931407942238, ROIC 23.465703971119133, revenue growth 1y , 6m momentum 34.38628158844765
Sector percentiles: P/E , 6m momentum 39.147564469914045
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08115698651070136
Base cash flow: -96099000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OBCL.NS (Industrials — Trucking, India)
Report date: 2026-03-31 (annual)
Stock price: 0.5407720891824939
Market cap: 1104527360 (USD: 11705461.636286562)
P/B ratio: 1.431529629073887
Debt to equity: 0.863
Current ratio: 1.73
Interest coverage ratio: -0.9783184167401993
Return on net tangible assets (%): -25.685160029551252
Buffett classification: The Gruesome
Rule of 40 score: -9.193086289559444
Altman Z-score: 1.560751442818631 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -10.454614738361572, 3m -9.476945370038253, 6m -11.266859344894016, 12m -15.31138570714615, composite -8.722538018096655 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -2.344318768450937
Revenue deceleration: no
Revenue growth consistency score: 12.391760067314493
Accrual ratio: -0.0033941083555829483
FCF conversion rate: 0.9238708358880032
Beneish M-score: -3.2545048708183217 (Likely Safe)
ROE (%): -8.455675344585796
Net margin (%): -2.2547614295477776
Asset turnover: 1.97730672977824
Equity multiplier (leverage): 1.8965908820408743
ROE archetype: Low Return
Treasury beta 1y: -0.021371378215724813 (R-squared: 0.00038924735999411325)
Insider 90-day net shares: 422962 (net value USD: 253988.00)
ROIC (%): -2.8202994549092666 (pretax: -3.56999931001173)
Incremental ROIC 3y (%): -24.60072313514397 (pretax: -32.77087480971755)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 48.717948717948715, ROIC 76.92307692307693, revenue growth 1y 46.15384615384615, 6m momentum 74.35897435897436
Sector percentiles: P/E , 6m momentum 58.653353814644134
Industry median P/E: 6.559885845838838; industry median ROIC: 3.062543534284001
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: -2284389.57185248
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OBIO (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 3.74
Market cap: 223953872 (USD: 223953872)
P/B ratio: 6.178215157069334
Debt to equity: 0.311
Current ratio: 7.03
Return on net tangible assets (%): -50.37385900174791
Buffett classification: The Gruesome
Analyst consensus upside (%): 186.35294117647058
Rule of 40 score: -22904.108150929886
Altman Z-score: -2.809976260376233 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.047777695935527296
Total shareholder yield (%): 0.047777695935527296 (Low Return)
Momentum (%): 1m -6.030150753768838, 3m -9.443099273607741, 6m -7.425742574257422, 12m 16.149068322981368, composite 2.2445475413948395 (Moderate Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -87.32718894009217
Revenue deceleration: no
Accrual ratio: 0.015739043686054336
FCF conversion rate: 1.0821068938807126
Beneish M-score: -2.9883863553110652 (Likely Safe)
ROE (%): -43.595534074840124
Net margin (%): -18778.18181818182
Asset turnover: 0.0010208106164304109
Equity multiplier (leverage): 2.2742766087672273
ROE archetype: Low Return
Treasury beta 1y: -0.002705741623129689 (R-squared: 0.000276719272469664)
Insider 90-day net shares: 9604 (net value USD: 35849.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 51.17328519855595, ROIC , revenue growth 1y 27.617328519855594, 6m momentum 33.03249097472924
Sector percentiles: P/E , 6m momentum 37.5
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07230710303063838
Base cash flow: -52863000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OLI.AX (Consumer Cyclical — Restaurants, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 3244391 (USD: 2162927.3333333335)
Debt to equity: -1.389461669858113
Current ratio: 0.16
Interest coverage ratio: -0.45589646683728796
Buffett classification: The Gruesome
Rule of 40 score: 3.1097848452496484
Altman Z-score: -4.138840859485388 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -216.63807308352682
Total shareholder yield (%): -216.63807308352682 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m 1.3888888888888886, 12m , composite -0.6944444444444456 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 8.53366202829957
Net income growth 1y (%): -139.52356774420494
Revenue CAGR 3y (%): -5.917409310240895
Revenue deceleration: yes
Revenue growth consistency score: 31.66429242840664
Accrual ratio: -0.07280816735658453
FCF conversion rate: 0.6187970896759067
Beneish M-score: -2.4691330467224724 (Likely Safe)
Net margin (%): -8.765195042999727
Asset turnover: 2.1790254746274917
ROE archetype: Standard Business
Treasury beta 1y: 0.008312072467891339 (R-squared: 0.00019191764402153025)
Insider 90-day net shares: 100000000 (net value USD: 900000.00)
ROIC (%): -7.329268617323917 (pretax: -9.277555211802426)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC 75.74626865671642, revenue growth 1y 13.432835820895523, 6m momentum 25.74626865671642
Sector percentiles: P/E , 6m momentum 30.493741307371348
Industry median P/E: 0.6179805059642126; industry median ROIC: 6.022634691026258
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: -2090156.6666666667
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OLL.AX (Technology — Software - Application, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.01388888888888889
Market cap: 14860655 (USD: 9973593.959731543)
P/B ratio: 29.11078354306473
Debt to equity: 0
Current ratio: 0.87
Interest coverage ratio: -45.66077547547317
Buffett classification: The Gruesome
Rule of 40 score: -28.69089278973479
Altman Z-score: -14.216531691031713 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -35.18518518518518, 6m -49.30555555555556, 12m 4.861111111111119, composite -26.784269902085985 (Flat)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.4105686683455454
FCF conversion rate: 0.6157475348403053
Beneish M-score: -0.051125852173655395 (Strong Manipulation Signal)
ROE (%): -2108.5468122678044
Net margin (%): -128.73687905396892
Asset turnover: 0.8299772059018182
Equity multiplier (leverage): 19.73395373259759
ROE archetype: Low Return
Treasury beta 1y: 0.001843412240614299 (R-squared: 9.719735686711013e-06)
Insider 90-day net shares: 133333 (net value USD: 1373.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 73.45013477088949, ROIC , revenue growth 1y , 6m momentum 83.9622641509434
Sector percentiles: P/E , 6m momentum 77.37737737737737
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.1074
Base cash flow: -2375108.0536912754
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OLLI (Consumer Defensive — Discount Stores, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 66.31
Market cap: 4008657664 (USD: 4008657664)
P/E ratio: 21.413366336633665
P/B ratio: 2.7669716038952727
Debt to equity: 0.37579999999999997
Current ratio: 2.32
Return on net tangible assets (%): 5.841635266000756
Buffett classification: The Great
Analyst consensus upside (%): 26.1472662119986
Rule of 40 score: -12.918206202260599
Altman Z-score: 3.4804474840726143 (Safe Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 4.674281335164528, earnings yield % 1.7004315114739612, rank 996
Dividend yield (%): 0
Buyback yield (%): 1.331268580983023
Debt paydown yield (%): -0.6078842855262584
Total shareholder yield (%): 0.7233842954567645 (Low Return)
Momentum (%): 1m -10.500742340396815, 3m -26.52631578947368, 6m -41.38601608768673, 12m -49.66982922201139, composite -37.225679253171116 (Strong Downtrend)
Lynch category: Stalwart (confidence: Medium)
Screener: long score 6, short score 1, recommendation: Neutral
Revenue growth 1y (%): 14.245093772701978
Net income growth 1y (%): 18.5870479394449
Revenue deceleration: no
Revenue growth consistency score: 1.8173916121178653
Accrual ratio: 0.012228577883598381
FCF conversion rate: 0.3550886524822695
Beneish M-score: -2.155303442422796 (Likely Safe)
ROE (%): 2.985578702024953
Net margin (%): 8.559357016244567
Asset turnover: 0.22153114584124803
Equity multiplier (leverage): 1.5745359780761121
ROE archetype: Low Return
P/E z-score: 3.965428929218277
FCF z-score: 3.965428929218276
Treasury beta 1y: -0.002687637210611848 (R-squared: 0.0009215764320562264)
Insider 90-day net shares: -12459 (net value USD: -1149218.00)
ROIC (%): 10.78221632595545 (pretax: 14.17862612043047)
Incremental ROIC 3y (%): 18.261856295552565 (pretax: 24.198182264667953)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 48.484848484848484, P/B 12.121212121212121, ROIC 54.54545454545454, revenue growth 1y 12.121212121212121, 6m momentum 84.84848484848484
Sector percentiles: P/E 54.16364952932658, 6m momentum 76.24909485879797
Industry median P/E: 17.960177849712736; industry median ROIC: 12.316287845972834
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.07070975699577602
Base cash flow: 295532000
DCF price per share: base 251.77932587988238, conservative 135.28366725816238, aggressive 468.57338076700364
Financial scorecard for ORGO (Healthcare — Drug Manufacturers - Specialty & Generic, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.39
Market cap: 307532160 (USD: 307532160)
P/E ratio: 112.15839601324018
P/B ratio: 0.7996881547776697
Debt to equity: 0.1858
Current ratio: 3.53
Return on net tangible assets (%): -12.582990107063683
Buffett classification: The Gruesome
Analyst consensus upside (%): 26.58227848101265
Rule of 40 score: -44.32155744263994
Altman Z-score: 1.256178838642308 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 13.254049591482337, earnings yield % 13.182677167970294, rank 1657
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.666608396338126
Total shareholder yield (%): 3.666608396338126 (Low Return)
Momentum (%): 1m -2.049180327868845, 3m 1.7021276595744694, 6m -39.03061224489795, 12m -49.68421052631579, composite -28.653354510897298 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): -58.18578201238854
Revenue deceleration: no
Accrual ratio: -0.12717547344201688
FCF conversion rate: -0.338268492738355
Beneish M-score: -1.3934949617833752 (Strong Manipulation Signal)
ROE (%): -13.040177120322841
Net margin (%): -146.63724137931032
Asset turnover: 0.06480609123624993
Equity multiplier (leverage): 1.37221884908588
ROE archetype: Low Return
P/E z-score: 4.3678728842106205
Treasury beta 1y: 0.020544611959825994 (R-squared: 0.014337860310901252)
Insider 90-day net shares: -185000 (net value USD: -986967.00)
ROIC (%): 10.428654331940566 (pretax: 13.22731405193477)
Incremental ROIC 3y (%): 19.917929150959353 (pretax: 24.79061110536656)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 54.83870967741935, P/B 16.422287390029325, ROIC 29.61876832844575, revenue growth 1y 70.08797653958945, 6m momentum 78.2991202346041
Sector percentiles: P/E 33.30945558739255, 6m momentum 64.75644699140402
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11266596166861839
Base cash flow: 49819000
DCF price per share: base 6.601399325990389, conservative 4.926655043256323, aggressive 8.949470498538076
Financial scorecard for P (Technology — Computer Hardware, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 74.56
Market cap: 24784111616 (USD: 24784111616)
P/E ratio: 108.25757575757575
P/B ratio: 16.468834738007043
Debt to equity: 1.2736
Current ratio: 1.62
Interest coverage ratio: 83.42677824267783
Return on net tangible assets (%): -0.3861079516030758
Buffett classification: The Gruesome
Analyst consensus upside (%): 31.40657802659202
Rule of 40 score: -1.5468691283890994
Altman Z-score: 4.684072286771846 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 1.0074257163110607, earnings yield % 0.08199870450485688, rank 2764
Dividend yield (%): 0
Buyback yield (%): 0.33934240332304355
Debt paydown yield (%): -0.05748037380045989
Total shareholder yield (%): 0.28186202952258366 (Low Return)
Momentum (%): 1m 2.4175824175824245, 3m 4.381912361752758, 6m 6.896057347670253, 12m 30.898876404494384, composite 13.02898615782265 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 2, short score 10, recommendation: Neutral
Revenue growth 1y (%): 35.24936254391542
Revenue deceleration: no
Revenue growth consistency score: 10.534383216787978
Accrual ratio: -0.01860570535066827
FCF conversion rate: 4.641166209818091
Beneish M-score: -2.6814834238989382 (Likely Safe)
ROE (%): 1.6675635413182188
Net margin (%): 2.286835546910616
Asset turnover: 0.22344503080683933
Equity multiplier (leverage): 3.263448444944016
ROE archetype: Low Return
P/E z-score: 4.395279537047243
FCF z-score: 4.395279537047238
Treasury beta 1y: -0.0001643816842046314 (R-squared: 1.042583047577708e-06)
Insider 90-day net shares: -1392345 (net value USD: -114447366.00)
ROIC (%): 83.72215998584338 (pretax: 99.78446777445595)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 49.586776859504134, P/B 69.42148760330579, ROIC 4.132231404958678, revenue growth 1y 22.31404958677686, 6m momentum 38.01652892561984
Sector percentiles: P/E 52.45245245245245, 6m momentum 26.026026026026027
Industry median P/E: 8.88268187417684; industry median ROIC: 2.6060646680961477
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.12559500830920647
Base cash flow: 71652000
DCF price per share: base 7.646637366056284, conservative 6.540334438580491, aggressive 9.30025625946798
Financial scorecard for PA.V (Basic Materials — Gold, Canada)
Report date: 2025-12-31 (annual)
Stock price: 0.09929078014184399
Market cap: 13052877 (USD: 9527647.445255473)
P/B ratio: 19.40517205328825
Debt to equity: 0
Current ratio: 1.82
Return on net tangible assets (%): -293.85977973208577
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -2.637325719057948 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 8.456082924168047, 3m -28.406121687196702, 6m -37.717601547388774, 12m 12.5295508274232, composite -20.789284896661506 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.26895980740169684
FCF conversion rate: 1.411469454192119
Beneish M-score: -1.6535913619853884 (Possible Manipulation)
ROE (%): -741.9527131307477
Asset turnover: 0
Equity multiplier (leverage): 3.609272233904605
ROE archetype: Low Return
Treasury beta 1y: 0.002333705807822194 (R-squared: 0.00012848392522799975)
Insider 90-day net shares: 481000 (net value USD: 53588.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 61.18980169971672, ROIC , revenue growth 1y , 6m momentum 53.11614730878187
Sector percentiles: P/E , 6m momentum 61.57690172126596
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -1339749.6350364962
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PMEC (Industrials — Specialty Business Services, Singapore)
Report date: 2025-03-31 (annual)
Stock price: 0.5
Market cap: 19208994 (USD: 19208994)
P/B ratio: 2.7355051442468836
Debt to equity: 1.1747
Current ratio: 1.32
Interest coverage ratio: -0.8669201520912547
Buffett classification: The Gruesome
Rule of 40 score: 9.355512325596386
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 16.83338433711538
Total shareholder yield (%): 16.83338433711538 (High Return)
Momentum (%): 1m -32.432432432432435, 3m -28.571428571428566, 6m -47.368421052631575, 12m -66.66666666666666, composite -42.20217209690894 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 4, recommendation: Neutral
Revenue growth 1y (%): 3.281456184962339
Revenue CAGR 3y (%): 11.223194102675338
FCF CAGR 3y (%): 36.139400688571556
Revenue deceleration: yes
Revenue growth consistency score: 14.60926735844179
Accrual ratio: -0.1904786244771319
FCF conversion rate: -3.235839340885685
Beneish M-score: -3.831991269099388 (Likely Safe)
ROE (%): -13.109906037422514
Net margin (%): -2.6120055414329717
Asset turnover: 1.721601659524712
Equity multiplier (leverage): 2.9153641728075335
ROE archetype: Low Return
FCF z-score: 1.9253051476352088
Treasury beta 1y: -0.002285663929489616 (R-squared: 0.00012612092879178916)
Insider 90-day net shares: 839963 (net value USD: 586294.00)
ROIC (%): -2.7005847368684095 (pretax: -3.4184616922384934)
Incremental ROIC 3y (%): 1.5613750615833426 (pretax: 1.9764241285865063)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 58.620689655172406, ROIC 70.34482758620689, revenue growth 1y 22.06896551724138, 6m momentum 84.13793103448276
Sector percentiles: P/E , 6m momentum 82.51408090117768
Industry median P/E: 0.2625461273512518; industry median ROIC: 8.492361488286793
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.08013697064464406
Base cash flow: 752238.8059701492
DCF price per share: base 0.6151260915714358, conservative 0.33506887807136854, aggressive 1.087650240354219
Financial scorecard for PMI.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3475177304964539
Market cap: 18918760 (USD: 13610618.705035971)
P/B ratio: 2.8228372981420384
Debt to equity: 0
Current ratio: 3.797156937793512
Return on net tangible assets (%): -9.498533188327652
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 4.046818446267469 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -11.87943262411348, 3m -26.75395526459356, 6m -32.45430026970333, 12m , composite -29.604127767148448 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.007703215637792155
FCF conversion rate: 0.9276720278194124
Beneish M-score: -3.1919828160661448 (Likely Safe)
ROE (%): -12.496619076274156
Asset turnover: 0
Equity multiplier (leverage): 1.1733478061626934
ROE archetype: Low Return
Treasury beta 1y: 0.004358210546610131 (R-squared: 0.00048648591126963456)
Insider 90-day net shares: 42500 (net value USD: 15130.00)
ROIC (%): -101.61561044217476 (pretax: -128.6273549900946)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 34.47127393838468, ROIC 50.37468776019983, revenue growth 1y , 6m momentum 46.54454621149042
Sector percentiles: P/E , 6m momentum 57.27373681288174
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: -3091767.8832116784
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PML.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 1.1347517730496455
Market cap: 492817312 (USD: 354544828.77697843)
P/B ratio: 6.3429693273487935
Debt to equity: 0.0019
Current ratio: 0.11
Interest coverage ratio: -35.7785569358915
Return on net tangible assets (%): -10.193337856805968
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 12.16948369807126 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.20662077045850596
Total shareholder yield (%): 0.20662077045850596 (Low Return)
Momentum (%): 1m 15.096251266464039, 3m 55.46099290780143, 6m 184.7195357833656, 12m 221.51300236406627, composite 139.8410838986206 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.03576692573826712
FCF conversion rate: 0.4339504777077375
Beneish M-score: -2.6578040479715277 (Likely Safe)
ROE (%): -9.841529146744781
Asset turnover: 0
Equity multiplier (leverage): 1.5575263339393064
ROE archetype: Low Return
Treasury beta 1y: 0.005859939132776436 (R-squared: 0.0006840483518070552)
Insider 90-day net shares: 94860 (net value USD: 42144.00)
ROIC (%): -5.086889104499602 (pretax: -6.439100132277977)
Incremental ROIC 3y (%): -6.56195431751302 (pretax: -8.306271287991173)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 47.04412989175687, ROIC 15.570358034970857, revenue growth 1y , 6m momentum 1.2489592006661114
Sector percentiles: P/E , 6m momentum 0.6662965019433648
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -1810296.3503649635
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PROZONER.NS (Real Estate — Real Estate - Diversified, India)
Report date: 2026-03-31 (annual)
Stock price: 0.45210569777043763
Market cap: 6684005888 (USD: 70835162.01780416)
P/E ratio: 0.6185753474210955
P/B ratio: 1.2765277895448852
Debt to equity: 1.3462
Current ratio: 1.97
Interest coverage ratio: 1.2154606938994543
Return on net tangible assets (%): 9.845068143569256
Buffett classification: The Great
Rule of 40 score: 34.24404069435446
Altman Z-score: 0.7169544726246098 (Distress Zone)
Piotroski F-score: 8 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -8.40480988976105, 3m -33.51926997316268, 6m -23.4280471922655, 12m -6.795675763861094, composite -18.396842757650358 (Flat)
Lynch category: Turnaround (confidence: Low)
Screener: long score 0, short score 6, recommendation: Neutral
Revenue growth 1y (%): -9.787339034006736
Revenue deceleration: no
Revenue growth consistency score: 23.94497553624375
Beneish M-score: -2.454148747718651 (Likely Safe)
ROE (%): 1.3625834749748074
Net margin (%): 12.659831466017385
Asset turnover: 0.03706662417400182
Equity multiplier (leverage): 2.9037027695122304
ROE archetype: Low Return
P/E z-score: 3.3512372031695814
FCF z-score: 4.669800036531992
Treasury beta 1y: -3.0865887405230687e-06 (R-squared: 6.044443182760786e-10)
Insider 90-day net shares: -19434 (net value USD: -11366.00)
ROIC (%): 3.2647898892014457 (pretax: 5.022753675694531)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 40.54054054054054, P/B 56.75675675675676, ROIC 40.54054054054054, revenue growth 1y 35.13513513513514, 6m momentum 79.72972972972973
Sector percentiles: P/E 17.77950310559006, 6m momentum 65.99378881987577
Industry median P/E: 0.1786011340287656; industry median ROIC: 2.960519784941141
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.08714662069482217
Base cash flow: 3810852.055955914
DCF price per share: base 0, conservative 0, aggressive 0.0004655517023310218
Financial scorecard for PRQR (Healthcare — Biotechnology, Netherlands)
Report date: 2026-03-31 (quarterly)
Stock price: 1.72
Market cap: 242728928 (USD: 242728928)
P/B ratio: 5.290084799042503
Debt to equity: 0.41850000000000004
Current ratio: 2.48
Return on net tangible assets (%): -34.18532900686206
Buffett classification: The Gruesome
Analyst consensus upside (%): 409.25925925925924
Rule of 40 score: -684.1434225659498
Altman Z-score: -4.512647789963347 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2872621859934329
Total shareholder yield (%): 0.2872621859934329 (Low Return)
Momentum (%): 1m -4.9723756906077385, 3m 10.967741935483865, 6m -1.7142857142857157, 12m -23.893805309734507, composite -3.5526827345268672 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -52.426663410936705
Revenue deceleration: no
Accrual ratio: -0.01934312804351979
FCF conversion rate: 0.8450272734065606
Beneish M-score: -2.289725120687366 (Likely Safe)
ROE (%): -30.369753561699277
Net margin (%): -658.288243974422
Asset turnover: 0.01896074219502205
Equity multiplier (leverage): 2.4331553329111584
ROE archetype: Low Return
Treasury beta 1y: -0.00394234383582584 (R-squared: 0.0005062309486274154)
Insider 90-day net shares: 600000 (net value USD: 988425.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 47.3826714801444, ROIC , revenue growth 1y 24.819494584837546, 6m momentum 29.96389891696751
Sector percentiles: P/E , 6m momentum 31.303724928366762
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -47648235.29411765
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PRTA (Healthcare — Biotechnology, Ireland)
Report date: 2026-03-31 (quarterly)
Stock price: 8.75
Market cap: 458090816 (USD: 458090816)
P/E ratio: 3.382536546612268
P/B ratio: 1.4161780374862452
Debt to equity: 0.0245
Current ratio: 10.43
Return on net tangible assets (%): 10.525692862809324
Buffett classification: The Great
Analyst consensus upside (%): 120.16460905349791
Rule of 40 score: 11770.939196874346
Altman Z-score: 2.459929577371592 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 8.160804974132612, earnings yield % 21.75243251959726, rank 201
Dividend yield (%): 0
Buyback yield (%): 1.742865774016524
Debt paydown yield (%): 0.22984243497010684
Total shareholder yield (%): 1.972708208986631 (Low Return)
Momentum (%): 1m -6.91489361702128, 3m -18.6046511627907, 6m -12.5, 12m 30.597014925373127, composite 3.0646187666319555 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 10, short score 1, recommendation: Strong Long (L/S Compounder)
Revenue growth 1y (%): -12.098890991562195
Revenue deceleration: no
Accrual ratio: 0.011233402033089675
FCF conversion rate: 0.8825219278139422
Beneish M-score: 94.3758651862198 (Strong Manipulation Signal)
ROE (%): 10.912649328776045
Net margin (%): 1391.9427812612007
Asset turnover: 0.006869626227233015
Equity multiplier (leverage): 1.1412366456846934
ROE archetype: Standard Business
Treasury beta 1y: -0.010862539778506439 (R-squared: 0.009285688982150493)
Insider 90-day net shares: 345000 (net value USD: 3097110.00)
Incremental ROIC 3y (%): -93.60034866390023 (pretax: -118.48145400493702)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 5.6859205776173285, P/B 16.15523465703971, ROIC , revenue growth 1y 20.487364620938628, 6m momentum 36.64259927797834
Sector percentiles: P/E 16.69054441260745, 6m momentum 42.693409742120345
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -286276470.5882353
DCF price per share: base 0, conservative 0, aggressive 0